SEC Filing Summary: BioSig Technologies, Inc.
Business Context and Reporting Period
This Form 8-K Current Report was filed by BioSig Technologies, Inc. (not Streamex Corp.) on July 31, 2017. The registrant is a Delaware corporation headquartered in Minneapolis, Minnesota, and is classified as an emerging growth company.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance changes and does not contain financial statements or performance data.
Material Changes
On July 31, 2017, the Board of Directors appointed Kenneth Londoner as Chief Executive Officer (CEO), effective immediately. Mr. Londoner, who previously served as the Company's executive chairman and director, was also designated as the "principal executive officer" for SEC reporting purposes. He will continue to serve as executive chairman and director. No material new contracts or compensatory arrangements were entered into in connection with this appointment.
Guidance, Outlook, and Risks
The filing contains no guidance, outlook, management commentary on financial performance, or discussion of risks and contingencies. The document strictly reports the executive appointment.
Investor Verification Checklist
- Verify the correct registrant name is BioSig Technologies, Inc., as the input metadata referenced "Streamex Corp."
- Confirm the effective date of Kenneth Londoner's appointment as CEO (July 31, 2017).
- Review the Company's most recent 10-K or 10-Q filings for financial metrics, as this 8-K contains none.
- Check for any subsequent filings regarding the departure of the previous CEO, if applicable.